Patents Assigned to Analgesic Neuropharmaceuticals, LLC
  • TREATMENT OF NEUROPATHIC PAIN WITH N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTAGONISTS
    Publication number: 20130123295
    Abstract: Central neuropathic pain is treated with an analgesic composition that consists essentially of an N-methyl-D-aspartate (NMDA) receptor antagonist. In one embodiment, the invention includes chronic administration of the (NMDA) receptor antagonist. In another embodiment, the invention is use of an NMDA receptor antagonist or component thereof for the manufacture of a medicament than includes an analgesic component that consists essentially of an NMDA receptor antagonist for the chronic treatment of central neuropathic pain.
    Type: Application
    Filed: October 5, 2012
    Publication date: May 16, 2013
    Applicant: ANALGESIC NEUROPHARMACEUTICALS, LLC
    Inventor: ANALGESIC NEUROPHARMACEUTICALS, LLC
  • Treatment of central neuropathic pain
    Patent number: 8309570
    Abstract: Central neuropathic pain is treated with an analgesic composition that consists essentially of an N-methyl-D-aspartate (NMDA) receptor antagonist. In one embodiment, the invention includes chronic administration of the (NMDA) receptor antagonist. In another embodiment, the invention is use of an NMDA receptor antagonist or component thereof for the manufacture of a medicament than includes an analgesic component that consists essentially of an NMDA receptor antagonist for the chronic treatment of central neuropathic pain.
    Type: Grant
    Filed: June 7, 2001
    Date of Patent: November 13, 2012
    Assignee: Analgesic Neuropharmaceuticals, LLC
    Inventor: Christine Nai-Mei Sang